nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Osteoarthritis—Dexamethasone—psoriatic arthritis	0.0038	0.0038	CcSEcCtD
Verteporfin—Osteoarthritis—Betamethasone—psoriatic arthritis	0.0038	0.0038	CcSEcCtD
Verteporfin—Muscular weakness—Triamcinolone—psoriatic arthritis	0.0037	0.0037	CcSEcCtD
Verteporfin—Muscular weakness—Methylprednisolone—psoriatic arthritis	0.00369	0.00369	CcSEcCtD
Verteporfin—Influenza—Triamcinolone—psoriatic arthritis	0.00362	0.00362	CcSEcCtD
Verteporfin—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.00346	0.00346	CcSEcCtD
Verteporfin—Myocardial infarction—Prednisolone—psoriatic arthritis	0.00344	0.00344	CcSEcCtD
Verteporfin—Conjunctivitis—Prednisolone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Verteporfin—Muscular weakness—Betamethasone—psoriatic arthritis	0.00336	0.00336	CcSEcCtD
Verteporfin—Muscular weakness—Dexamethasone—psoriatic arthritis	0.00336	0.00336	CcSEcCtD
Verteporfin—Osteoarthritis—Prednisone—psoriatic arthritis	0.00331	0.00331	CcSEcCtD
Verteporfin—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Verteporfin—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.00318	0.00318	CcSEcCtD
Verteporfin—Haemoglobin—Prednisolone—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Verteporfin—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Verteporfin—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.00316	0.00316	CcSEcCtD
Verteporfin—Haemorrhage—Prednisolone—psoriatic arthritis	0.00315	0.00315	CcSEcCtD
Verteporfin—Photosensitivity—Methotrexate—psoriatic arthritis	0.00315	0.00315	CcSEcCtD
Verteporfin—Conjunctivitis—Triamcinolone—psoriatic arthritis	0.00314	0.00314	CcSEcCtD
Verteporfin—Sweating—Methylprednisolone—psoriatic arthritis	0.00309	0.00309	CcSEcCtD
Verteporfin—Visual impairment—Prednisolone—psoriatic arthritis	0.00304	0.00304	CcSEcCtD
Verteporfin—Muscular weakness—Prednisone—psoriatic arthritis	0.00292	0.00292	CcSEcCtD
Verteporfin—Visual disturbance—Methotrexate—psoriatic arthritis	0.00292	0.00292	CcSEcCtD
Verteporfin—Haemoglobin—Triamcinolone—psoriatic arthritis	0.00292	0.00292	CcSEcCtD
Verteporfin—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Verteporfin—Haemorrhage—Triamcinolone—psoriatic arthritis	0.0029	0.0029	CcSEcCtD
Verteporfin—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.00289	0.00289	CcSEcCtD
Verteporfin—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.00289	0.00289	CcSEcCtD
Verteporfin—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.00289	0.00289	CcSEcCtD
Verteporfin—Pharyngitis—Triamcinolone—psoriatic arthritis	0.00288	0.00288	CcSEcCtD
Verteporfin—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Verteporfin—Myocardial infarction—Betamethasone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Verteporfin—Conjunctivitis—Dexamethasone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Verteporfin—Conjunctivitis—Betamethasone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Verteporfin—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Verteporfin—Osteoarthritis—Methotrexate—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Verteporfin—Eye disorder—Methylprednisolone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Verteporfin—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Verteporfin—Haemoglobin—Dexamethasone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Verteporfin—Haemoglobin—Betamethasone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Verteporfin—Haemorrhage—Betamethasone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Verteporfin—Haemorrhage—Dexamethasone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Verteporfin—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Verteporfin—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Verteporfin—Vision blurred—Prednisolone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Verteporfin—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Verteporfin—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Verteporfin—Visual impairment—Betamethasone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Verteporfin—Visual impairment—Dexamethasone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Verteporfin—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Verteporfin—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Verteporfin—Myocardial infarction—Prednisone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Verteporfin—Malaise—Prednisolone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Verteporfin—Vertigo—Prednisolone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Verteporfin—Syncope—Prednisolone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Verteporfin—Eye disorder—Dexamethasone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Verteporfin—Eye disorder—Betamethasone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Verteporfin—Back pain—Triamcinolone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Verteporfin—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Verteporfin—Angiopathy—Betamethasone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Verteporfin—Angiopathy—Dexamethasone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Verteporfin—Hypertension—Prednisolone—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Verteporfin—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Verteporfin—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Verteporfin—Discomfort—Prednisolone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Verteporfin—Haemoglobin—Prednisone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Verteporfin—Haemorrhage—Prednisone—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Verteporfin—Malaise—Triamcinolone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Verteporfin—Malaise—Methylprednisolone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Verteporfin—Vertigo—Triamcinolone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Verteporfin—Syncope—Triamcinolone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Verteporfin—Vertigo—Methylprednisolone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Verteporfin—Syncope—Methylprednisolone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Verteporfin—Oedema—Prednisolone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Verteporfin—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Verteporfin—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Verteporfin—Shock—Prednisolone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Verteporfin—Cough—Triamcinolone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Verteporfin—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Verteporfin—Hypertension—Triamcinolone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Verteporfin—Hypertension—Methylprednisolone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Verteporfin—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Verteporfin—Pneumonia—Methotrexate—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Verteporfin—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Verteporfin—Eye disorder—Prednisone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Verteporfin—Flushing—Prednisone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Verteporfin—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Verteporfin—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Verteporfin—Discomfort—Triamcinolone—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Verteporfin—Discomfort—Methylprednisolone—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Verteporfin—Angiopathy—Prednisone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Verteporfin—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Verteporfin—Immune system disorder—Prednisone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Verteporfin—Malaise—Betamethasone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Verteporfin—Malaise—Dexamethasone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Verteporfin—Oedema—Triamcinolone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Verteporfin—Vertigo—Dexamethasone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Verteporfin—Vertigo—Betamethasone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Verteporfin—Syncope—Betamethasone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Verteporfin—Syncope—Dexamethasone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Verteporfin—Sweating—Methotrexate—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Verteporfin—Shock—Triamcinolone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Verteporfin—Shock—Methylprednisolone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Verteporfin—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Verteporfin—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Verteporfin—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Verteporfin—Skin disorder—Methylprednisolone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Verteporfin—Malnutrition—Prednisone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Verteporfin—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Verteporfin—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Verteporfin—Hypertension—Dexamethasone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Verteporfin—Hypertension—Betamethasone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Verteporfin—Discomfort—Dexamethasone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Verteporfin—Discomfort—Betamethasone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Verteporfin—Haemoglobin—Methotrexate—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Verteporfin—Pain—Prednisolone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Verteporfin—Haemorrhage—Methotrexate—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Verteporfin—Pharyngitis—Methotrexate—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Verteporfin—Vision blurred—Prednisone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Verteporfin—Oedema—Betamethasone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Verteporfin—Oedema—Dexamethasone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Verteporfin—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Verteporfin—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Verteporfin—Visual impairment—Methotrexate—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Verteporfin—Anaemia—Prednisone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Verteporfin—Shock—Dexamethasone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Verteporfin—Shock—Betamethasone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Verteporfin—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Verteporfin—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Verteporfin—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Verteporfin—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Verteporfin—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Verteporfin—Malaise—Prednisone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Verteporfin—Vertigo—Prednisone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Verteporfin—Eye disorder—Methotrexate—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Verteporfin—Syncope—Prednisone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Verteporfin—Urticaria—Prednisolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Verteporfin—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Verteporfin—Pain—Triamcinolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Verteporfin—Loss of consciousness—Prednisone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Verteporfin—Angiopathy—Methotrexate—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Verteporfin—Immune system disorder—Methotrexate—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Verteporfin—Hypertension—Prednisone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Verteporfin—Arthralgia—Prednisone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Verteporfin—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Verteporfin—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Verteporfin—Discomfort—Prednisone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Verteporfin—Malnutrition—Methotrexate—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Verteporfin—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Verteporfin—Urticaria—Triamcinolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Verteporfin—Urticaria—Methylprednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Verteporfin—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Verteporfin—Oedema—Prednisone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Verteporfin—Back pain—Methotrexate—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Verteporfin—Shock—Prednisone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Verteporfin—Pain—Dexamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Verteporfin—Pain—Betamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Verteporfin—Nervous system disorder—Prednisone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Verteporfin—Skin disorder—Prednisone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Verteporfin—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Verteporfin—Vision blurred—Methotrexate—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Verteporfin—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Verteporfin—Anaemia—Methotrexate—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Verteporfin—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Verteporfin—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Verteporfin—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Verteporfin—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Verteporfin—Malaise—Methotrexate—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Verteporfin—Vertigo—Methotrexate—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Verteporfin—Urticaria—Dexamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Verteporfin—Urticaria—Betamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Verteporfin—Dizziness—Prednisolone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Verteporfin—Asthenia—Triamcinolone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Verteporfin—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Verteporfin—Body temperature increased—Betamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Verteporfin—Asthenia—Methylprednisolone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Verteporfin—Pruritus—Triamcinolone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Verteporfin—Cough—Methotrexate—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Verteporfin—Pruritus—Methylprednisolone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Verteporfin—Arthralgia—Methotrexate—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Verteporfin—Chest pain—Methotrexate—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Verteporfin—Rash—Prednisolone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Verteporfin—Dermatitis—Prednisolone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Verteporfin—Headache—Prednisolone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Verteporfin—Discomfort—Methotrexate—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Verteporfin—Constipation—Prednisone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Verteporfin—Dizziness—Triamcinolone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Verteporfin—Dizziness—Methylprednisolone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Verteporfin—Feeling abnormal—Prednisone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Verteporfin—Asthenia—Betamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Verteporfin—Asthenia—Dexamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Verteporfin—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Verteporfin—Nausea—Prednisolone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Verteporfin—Pruritus—Dexamethasone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Verteporfin—Pruritus—Betamethasone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Verteporfin—Skin disorder—Methotrexate—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Verteporfin—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Verteporfin—Rash—Triamcinolone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Verteporfin—Dermatitis—Triamcinolone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Verteporfin—Rash—Methylprednisolone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Verteporfin—Dermatitis—Methylprednisolone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Verteporfin—Urticaria—Prednisone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Verteporfin—Headache—Triamcinolone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Verteporfin—Headache—Methylprednisolone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Verteporfin—Body temperature increased—Prednisone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Verteporfin—Dizziness—Betamethasone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Verteporfin—Dizziness—Dexamethasone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Verteporfin—Nausea—Triamcinolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Verteporfin—Nausea—Methylprednisolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Verteporfin—Dyspnoea—Methotrexate—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Verteporfin—Hypersensitivity—Prednisone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Verteporfin—Rash—Betamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Verteporfin—Rash—Dexamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Verteporfin—Dermatitis—Betamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Verteporfin—Dermatitis—Dexamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Verteporfin—Headache—Betamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Verteporfin—Headache—Dexamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Verteporfin—Asthenia—Prednisone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Verteporfin—Pain—Methotrexate—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Verteporfin—Pruritus—Prednisone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Verteporfin—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Verteporfin—Nausea—Dexamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Verteporfin—Nausea—Betamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Verteporfin—Urticaria—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Verteporfin—Dizziness—Prednisone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Verteporfin—Body temperature increased—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Verteporfin—Rash—Prednisone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Verteporfin—Dermatitis—Prednisone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Verteporfin—Headache—Prednisone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Verteporfin—Hypersensitivity—Methotrexate—psoriatic arthritis	0.001	0.001	CcSEcCtD
Verteporfin—Asthenia—Methotrexate—psoriatic arthritis	0.000976	0.000976	CcSEcCtD
Verteporfin—Nausea—Prednisone—psoriatic arthritis	0.000967	0.000967	CcSEcCtD
Verteporfin—Pruritus—Methotrexate—psoriatic arthritis	0.000963	0.000963	CcSEcCtD
Verteporfin—Dizziness—Methotrexate—psoriatic arthritis	0.0009	0.0009	CcSEcCtD
Verteporfin—Rash—Methotrexate—psoriatic arthritis	0.000858	0.000858	CcSEcCtD
Verteporfin—Dermatitis—Methotrexate—psoriatic arthritis	0.000857	0.000857	CcSEcCtD
Verteporfin—Headache—Methotrexate—psoriatic arthritis	0.000853	0.000853	CcSEcCtD
Verteporfin—Nausea—Methotrexate—psoriatic arthritis	0.000808	0.000808	CcSEcCtD
